https://www.biopharmadive.com/news/lilly-versanis-obesity-drug-acquire-deal/687539/
Lilly to buy Versanis, adding to obesity drug pipeline | BioPharma Dive
The pharma will pay up to $1.9 billion to acquire the privately held biotech and its experimental antibody, which Lilly plans to pair with its own weight loss...
to buydrug pipelinelillyaddingobesity